Biolife Solutions Inc (NASDAQ: BLFS)’s Stock Is Down -2.50% Since The Beginning Of The Year, Likely To Sustain The Trend In 2024

During the last session, Biolife Solutions Inc (NASDAQ:BLFS)’s traded shares were 0.39 million, with the beta value of the company hitting 1.70. At the end of the trading day, the stock’s price was $17.53, reflecting an intraday gain of 3.97% or $0.67. The 52-week high for the BLFS share is $24.50, that puts it down -39.76 from that peak though still a striking 49.12% gain since the share price plummeted to a 52-week low of $8.92. The company’s market capitalization is $794.11M, and the average trade volume was 374.66K shares over the past three months.

Biolife Solutions Inc (NASDAQ:BLFS) trade information

Biolife Solutions Inc (BLFS) registered a 3.97% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 3.97% in intraday trading to $17.53, hitting a weekly high. The stock’s 5-day price performance is 10.53%, and it has moved by -5.04% in 30 days. Based on these gigs, the overall price performance for the year is -2.50%.

Biolife Solutions Inc (BLFS) estimates and forecasts

Statistics show that Biolife Solutions Inc has outperformed its competitors in share price, compared to the industry in which it operates. Biolife Solutions Inc (BLFS) shares have gone up 83.95% during the last six months, with a year-to-date growth rate more than the industry average at 56.58% against 18.30. In the rating firms’ projections, revenue will decrease -26.20% compared to the previous financial year.

As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 2.75B as predicted by 8 analyst(s). Meanwhile, a consensus of 8 analyst(s) estimates revenue growth to 24.19M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 37.7M and 39.51M respectively. In this case, analysts expect current quarter sales to grow by 7,193.30% and then drop by -38.80% in the coming quarter.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 0.51%. While earnings are projected to return 42.31% in 2024, the next five years will return 10.00% per annum.

BLFS Dividends

Biolife Solutions Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Biolife Solutions Inc (NASDAQ:BLFS)’s Major holders